In terms of revenue, the Global Patient Controlled Injectors Market is expected to reach by 2030, growing at a CAGR (Compound Annual Growth Rate) of 12.8% from 2023 to 2030.
The market refers to the need for devices that allow patients to self-administer medication through injections. These devices give patients greater control over their medication, allowing them to administer the appropriate dose at the right time. In addition, enables patients to take control of their treatment, leading to improved medication adherence, reduced healthcare costs, and increased patient satisfaction. Furthermore, are particularly beneficial for patients requiring frequent injections or having mobility limitations, as they eliminate the need for healthcare professional assistance.
The market is anticipated to expand significantly during the next few years. Some variables causing this growth include the rise in chronic disease incidence and the increasing need for self-medication. offer several advantages over traditional injection methods, such as ease of use, reduced pain during injection, and improved patient compliance.
Key Highlights from the Report
- Based on Product, the Electronic Wearable Injector segment dominates the Patient Controlled Injectors market owing to the increasing prevalence of chronic diseases, technological advancements, improved patient experience, and targeted therapies.
- Based on Application, the Cancer Treatment segment accounted for the substantial growth of the market in 2022 owing to the increasing prevalence of cancer, the advantages offered by these devices, advancements in technology, and the focus on personalized medicine.
- Based on the Distribution Channel, the Hospital Pharmacies are anticipated to see the most significant market expansion in 2022 due to their capacity to offer complete pharmaceutical services and proficiency in overseeing sophisticated drug delivery systems.
- Based on Region, North America holds the significant market share within the Patient Controlled Injectors market in 2022 owing to the increased frequency of chronic diseases, the rising need for self-administered medications, and improvements in medical technology.
The growing preference for home healthcare and self-care also propels the market for . With the rising healthcare costs and the desire for more personalized and convenient healthcare options, patients are increasingly opting to receive treatments and manage their conditions at home. enable patients to self-administer medications safely and effectively, thereby reducing the need for hospital visits and improving patient outcomes. Furthermore, technological advancements are also contributing to the growth of the market. Developing innovative devices with features such as dose adjustment options, data connectivity, and feedback mechanisms has made self-administration safer and more efficient. For example, some are equipped with electronic monitoring systems that track and record the dosage and timing of injections, providing healthcare professionals with valuable insights into patient adherence and treatment effectiveness.
North America has witnessed substantial growth in 2022 and is expected to grow significantly in the forecast period. Numerous variables, including the rising incidence of chronic diseases, the rise in demand for self-administered medications, and improvements in medical technology, can be credited for this expansion. Furthermore, there is a growing demand for self-administered medications among patients. offer a convenient and user-friendly way to administer medication at home, improving medication adherence and overall patient outcomes. This is crucial for people with chronic diseases who need to take their medications regularly.
The Global Patient Controlled Injectors Market is Segmented as follows
- Electronic Wearable Injector
- Mechanical Wearable Injector
- Infusion Pumps
- Cancer Treatment
- Auto-immune Treatment
- Blood Disorders Treatment
- Other Applications
- Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
List of the Key Players of the Global Patient Controlled Injectors Market is
West Pharmaceutical Services Inc. (U.S.), Gerresheimer AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Johnson and Johnson Services Inc. (U.S.), Ypsomed AG (Switzerland), Westbourne Medical Limited (UK), Enable Injections (U.S.), SCPharmaceuticals Inc. (U.S.), United Therapeutics Corporation (U.S.), Becton Dickinson and Company (U.S.)
The Global Patient Controlled Injectors Market Scope can be Tabulated as below
|Market Size Provided for Years||2017 - 2030|
|Historic Years||2017 - 2021|
|Forecast Years||2023 - 2030|
|Regions & Counties Covered||
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis|